Last $80.41 USD
Change Today +2.68 / 3.45%
Volume 557.2K
CVD On Other Exchanges
Symbol
Exchange
New York
Stuttgart
As of 8:04 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

covance inc (CVD) Snapshot

Open
$78.08
Previous Close
$77.73
Day High
$81.07
Day Low
$78.08
52 Week High
04/3/14 - $106.50
52 Week Low
10/15/14 - $73.57
Market Cap
4.5B
Average Volume 10 Days
475.0K
EPS TTM
$3.55
Shares Outstanding
56.5M
EX-Date
--
P/E TM
22.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for COVANCE INC (CVD)

covance inc (CVD) Related Bloomberg News

View More Bloomberg News

covance inc (CVD) Related Businessweek News

View More BusinessWeek News

covance inc (CVD) Details

Covance Inc. provides early-and late-stage services to the pharmaceutical, biotechnology, and medical device industries. Its early-stage development services include preclinical and clinical pharmacology services. The company’s late-stage services include biomarker services to biotech and pharmaceutical customers, with full management of Phase II and III clinical studies. It also provides lab testing services to the chemical, agrochemical, and food industries. The company was founded in 1987 and is based in Princeton, N.J.

11,863 Employees
Last Reported Date: 02/27/14
Founded in 1987

covance inc (CVD) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.0M
Chief Financial Officer and Corporate Senior ...
Total Annual Compensation: $407.5K
Executive Vice President and Group President ...
Total Annual Compensation: $455.5K
Executive Vice President and Group President ...
Total Annual Compensation: $421.0K
Chief Information Officer, Corporate Senior V...
Total Annual Compensation: $446.0K
Compensation as of Fiscal Year 2013.

covance inc (CVD) Key Developments

Covance Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 09:10 AM

Covance Inc. Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 09:10 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Joseph L. Herring, Chairman and Chief Executive Officer.

Covance Inc. Presents at 5th Annual Credit Suisse Small & Mid Cap Conference, Sep-16-2014 10:10 AM

Covance Inc. Presents at 5th Annual Credit Suisse Small & Mid Cap Conference, Sep-16-2014 10:10 AM. Venue: The Waldorf Astoria, 301 Park Avenue (between 49th & 50th Streets), New York, New York, United States. Speakers: Alison A. Cornell, Chief Financial Officer and Corporate Senior Vice President, Paul Surdez, VP, Investor Relations.

Covance Seeks Acquisitions

Covance Inc. (NYSE:CVD) is seeking acquisitions. Joe Herring, Chairman and Chief Executive Officer of Covance, said, "Our business is very, very well positioned. We're investing to expand capacity capabilities in three different locations. We're evaluating a number of acquisitions. We are very committed to this business. It leverages a lot of the tools, instrumentation, scientific talents that we have, you know, in pharmaceutical chemistry. We're expanding in Singapore. And then looking at acquisitions in Latin America, as well as either buy or build in a couple of other Asian markets. So we're definitely going global in this business but trying to do it in a smart and thoughtful and high quality way, and, you know, in a responsible way. We just are really proud of our team's effort to, you know, take the feedback, become more competitive, and win some very significant projects in support of commercial launch, as well as their creative ability to go out and find some really interesting acquisition candidates like the Medaxial.”

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVD:US $80.41 USD +2.68

CVD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Catalent Inc $25.19 USD +1.23
ICON PLC $56.91 USD +0.97
IMS Health Holdings Inc $25.35 USD +0.20
STERIS Corp $56.68 USD +0.42
West Pharmaceutical Services Inc $45.15 USD +0.18
View Industry Companies
 

Industry Analysis

CVD

Industry Average

Valuation CVD Industry Range
Price/Earnings 28.3x
Price/Sales 1.7x
Price/Book 2.7x
Price/Cash Flow 15.2x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVANCE INC, please visit www.covance.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.